您好,欢迎您

泰慧谈·圆桌交流|钟立业、Ravi Parikh、徐佳岱、邢宏运教授:AI赋能骨髓瘤,共探智慧诊疗新范式

09月24日

整理:肿瘤资讯

来源:肿瘤资讯


仅供医学药学专业人士参考,严禁翻印及传播

材料中涉及的案例为教学案例且已进行打码、遮盖等脱敏处理,相关信息已获得相应授权和批准

本材料中表达的观点仅代表本人个人的观点,不能反映强生创新制药的观点


CNP-001133

Approved Date:2026-09-17


参考文献

[1] Moreau P, Garfall AL, van de Donk NWCJ, et al. Teclistamab in relapsed or refractory multiple myeloma. N Engl J Med. 2022;387(6):495-505. doi:10.1056/NEJMoa2203478.

[2] Clichet V, Harrivel V, Delette C, et al. Accurate classification of plasma cell dyscrasias is achieved by combining artificial intelligence and flow cytometry. Br J Haematol. 2022;196(5):1175-1183. doi:10.1111/bjh.17933.

[3]  Kim HN, Lee JH, Jung Y, Kwon JA, Yoon SY. Comprehensive performance assessment of the BMIA-12A system for bone marrow cell quantification in normal and hematological malignancy samples. Sci Rep. 2026;16:8798. doi:10.1038/s41598-026-39443-1.

[4] Wennmann M, Hielscher T, Kintzelé L, et al. Analyzing longitudinal wb-MRI data and clinical course in a cohort of former smoldering multiple myeloma patients: connections between MRI findings and clinical progression patterns. Cancers (Basel). 2021;13(5):961. doi:10.3390/cancers13050961.

[5] Maura F, Rajanna AR, Ziccheddu B, et al. Genomic classification and individualized prognosis in multiple myeloma. J Clin Oncol. 2024;42(16):1899-1912. doi:10.1200/JCO.23.01277.

[6]  Abdallah M, Nakken S, Bierkens M, et al. TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching. Nat Commun. 2026;17. doi:10.1038/s41467-026-70509.

[7] Lekadir K, Frangi AF, Porras AR, et al. FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare. BMJ. 2025;388:e081554. doi:10.1136/bmj-2024-081554.

[8] Cai Z, Xia Z, He AL, et al. Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC-1. Cancer. 2025;131(1):e35665. doi:10.1002/cncr.35665.

排版编辑:zgy

责任编辑:zika

版权声明

版权归肿瘤资讯所有。欢迎个人转发分享,其他任何媒体、网站如需转载或引用本网版权所有内容,须获得授权,且在醒目位置处注明“转自:良医汇-肿瘤医生APP”。